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A Primer for non-Biologists
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Department of Medical Biosciences, University of the Western Cape, Bellville, South Africa
With regard to biocompatibility, the cardinal requirement for dental implants and other 
medical devices that are in long-term contact with tissue is that the material does not 
cause any adverse effect to the patient. To warrant stability and function of the implant, 
proper osseointegration is a further prerequisite. Cells interact with the implant surface 
as the interface between bulk material and biological tissue. Whereas structuring, 
deposition of a thin film, or other modifications of the surface are crucial parameters 
in determining favorable adhesion of cells, corrosion of metal surfaces and release of 
ions can affect cell viability. Both parameters are usually tested using in vitro cytotoxicity 
and adhesion assays with bone or fibroblasts cells. For bioactive surface modifications, 
further tests should be considered for biocompatibility evaluation. Depending on the type 
of modification, this may include analysis of specific cell functions or the determination of 
antimicrobial activities. The latter is of special importance as bacteria and yeast present 
in the oral cavity can be introduced during the implantation process and this may lead to 
chronic infections and implant failure. An antimicrobial coating of the implant is a way to 
avoid that. This review describes the essential biocompatibility assays for evaluation of 
new implant materials required by International Organization for Standardization 10993 
and also provides an overview of recent test methods for specific coatings of dental 
implants.
Keywords: medical devices, biomaterial, biocompatibility, implants, coatings, cell adhesion, microorganisms
inTRODUCTiOn: wHY CHARACTeRiZe BiOCOMPATiBiLiTY?
The implantation of a medical device into the body is a surgical procedure that introduces injury 
followed by a healing process and a long-term contact with body tissue. Several interactions 
between the implant surface and the patient’s body happen which will be discussed in more detail 
later. The most important aspect here is that the implant material shall exist in close contact 
with body tissue without causing harm to the patient. To assure this, a sequence of specific tests 
has to be undertaken, before any new medical device can be declared fit for human use by the 
relevant health organization. That is what biocompatibility is about: a measurement of how safe 
and compatible a medical device, such as an implant, is with a biological system. As  we will 
see later, the specific physico-chemical properties and nano-structuring of the implant surface 
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are crucial for the adhesion, differentiation, and proper func-
tion of bone cells. This can be controlled by modification of 
the implant’s surface by, e.g., coating with a wide range of 
substances. From a Research & Development point of view, 
the observed interaction between implant and biological 
material (i.e., the outcome of a biocompatibility test) can be 
used to incrementally improve the (surface) properties until 
the desired physiological characteristics are achieved. One 
comprehensive definition of biocompatibility that captures 
the essence with respect to implant material, interaction with 
the body, and benefit for the patient was drafted by Williams 
(2008): “Biocompatibility refers to the ability of a biomaterial to 
perform its desired function with respect to a medical therapy, 
without eliciting and undesirable local or systemic effects in the 
recipient or beneficiary of that therapy, but generating the most 
appropriate beneficial cellular or tissue response in that specific 
situation, and optimizing the clinically relevant performance of 
that therapy.” Same author also defined biomaterial as “…a 
substance that has been engineered to take a form which, alone 
or as part of a complex system, is used to direct, by control of 
interactions with components of living systems, the course of any 
therapeutic or diagnostic procedure, …” (Williams, 2009).
wHAT neeDS TO Be inveSTiGATeD?
Biocompatibility characterization has to answer two essential 
questions: is the material safe for use within the human body? 
Also, does the material/device have the necessary physico-
chemical and mechanical properties to fulfill its purpose? The 
International Organization for Standardization (ISO) has drafted 
a set of international standards for the biological evaluation 
of medical devices (ISO 10993). Biocompatibility tests have to 
comply with the ISO 10993 for registration of medical devices 
in Europe, Asia, and USA. Some health administrations, such 
as the FDA (USA), may need additional testing requirements. 
ISO 10993 consists of 20 parts spanning a wide range of specific 
testing procedures from physico-chemical investigation of the 
device toward its interaction with cells and body. The required 
tests will be dependent on the specific use of the medical device 
and contact time with the human body. Part 1 of the ISO 10993 
can be used as a framework to select those tests. For dental 
implants with a contact period exceeding 30 days, several tests 
are required to determine its biocompatibility. This includes tests 
for cytotoxicity, sensitization, irritation or intracutaneous (skin) 
reactivity, acute and sub-chronic toxicity as well as genotoxicity, 
and implantation. For medical devices (e.g., electrodes, external 
prostheses) that are merely in contact with the skin surface, only 
the first three tests have to be performed.
In general, biocompatible tests can be divided into:
• Tests concerning the implant material, such as extend of 
degradation in biological fluids or identification of leachable 
substances.
• In vitro tests that examine the interaction of the implant with 
cells or microorganisms.
• In vivo animal tests that determine the effect of the implant on 
the body.
This review will focus on in vitro tests that evaluate the interac-
tion between implant surface and bone cells or microorganisms.
iMPLAnTATiOn AnD 
OSSeOinTeGRATiOn
A dental implant usually consists of three parts: the implant itself 
that is inserted directly into the jaw bone (endosseous implant) 
and the abutment that connects the implant to the overlying crone 
or denture (i.e., the visible part). Titanium or its alloys are usually 
used as implant material because of its unique capability of osse-
ointegration. Osseointegration means the formation of a direct 
interface between an implant and bone, without intervening soft 
tissue, cartilage, or protein layer (Karlsson et al., 2014). Titanium 
naturally forms a thin protective oxide film on its surface that 
can eventually transform into calcium phosphate apatite that then 
binds chemically with the bone (Monsees et al., 2005). Also, the 
interface between titanium implant and superficial soft tissue is 
similar to the union between tooth and gingivae. To enhance the 
osseointegration process, endosseous implants commonly have 
some sort of coating and/or surface modification (Table 1).
SURFACe inTeRACTiOnS
interaction: implant Surface 
with Bone Cells
For osseointegration to work, bone cells must make contact 
with the implant surface. Osteoblasts are those cells that build 
new or repair damaged bone. This is a complex process called 
osteogenesis and starts with the adhesion of osteoblasts to 
existing bone or the implant surface. Further events involve 
bone cell proliferation and differentiation, expression of bone 
cell-specific enzymes and products, secretion, and deposition of 
the organic bone matrix. When a bone cell, floating in interstitial 
fluid or blood, approaches the implant it only “feels” the device 
surface, not the bulk material. This surface displays charged and 
hydrogen-bond groups and lipophilic patches originating from 
either implant or adsorbed extracellular matrix. This matrix 
originates from adsorption of proteins from surrounding tissue 
fluid or blood and is also secreted by the bone cells. Typical matrix 
ligands are collagen type I and fibronectin. Some implants display 
those bio-adhesive ligands via their surface coating (Cohen et al., 
2004; Garcia and Reyes, 2005). Initially, there are weak and 
temporary interactions between charged or polar molecules of 
cell membrane and implant surface. Over time, those interactions 
can become stronger and more specific leading to permanent cell 
adhesion via binding of adhesion receptors (e.g., integrins, cad-
herins) located on the osteoblast cell membrane to extracellular 
matrix ligands present on the implant surface. After binding to an 
extracellular matrix ligand, the integrins associate with the actin 
cytoskeleton and cytoplasmic plaque proteins (e.g., vinculin) 
to form focal adhesions (Gumbiner, 1996). At a focal adhesion, 
the distance between cell membrane receptor and ligand on the 
implant surface drops to only 15 nm (Cohen et al., 2004). Focal 
adhesions are crucial for the spreading and flattening of a cell 
that is important to gain strong adhesion. Together with growth 
TABLe 1 | Overview on coatings for dental implants that improve 
osseointegration and/or prevent microbial colonization.
Surface modification Observed biological 
effect
Reference
Surface chemistry
Carbon implantation Improved blood 
compatibility
Lu et al. (2012)
Bisphosphonates Enhanced 
osseointegration, bone 
loss prevention
Abraham (2014)
Bone stimulating factors, 
growth factors
Augment healing of 
bone, increased and 
accelerated bone-to-
implant contact
Avila et al. (2009) and 
Moon et al. (2015)
Bioactive glass/ceramics Stimulate bone 
growth, enhanced 
osseointegration
Le Guéhennec et al. 
(2004)
Calcium phosphate Increased bone-to-
implant contact
Kim et al. (2015) and 
Van Oirschot et al. 
(2016)
Fluoride implantation Enhanced 
osseointegration and 
osteoblast differentiation
Sun et al. (2016)
Hydroxyapatite Increased bone-to-
implant contact and 
osteoblast differentiation
Abraham (2014) and 
Kikuchi (2013)
Titanium nitride Improved mechanical 
properties and blood 
compatibility
Lu et al. (2012)
Titanium oxide Enhanced 
osseointegration, 
improved blood 
compatibility
Abraham (2014), 
Huang et al. (2016), 
and Lu et al. (2012)
Surface patterning
Increased roughness by 
titanium plasma spraying, 
blasting with ceramic 
particles, acid-etching, or 
anodization
Increased bone-
to-implant contact, 
improved cell 
proliferation and 
differentiation
Anil et al. (2011), 
Jemat et al. (2015), 
and Novaez et al. 
(2010)
Nano-structuring Improved cell adhesion, 
orientation and 
differentiation; enhanced 
osseointegration
Dalby et al. (2008), 
Dohan Ehrenfest et al. 
(2010), and Monsees 
et al. (2005)
Antimicrobial coating
Prevent bacterial 
adhesion: smooth surface, 
sacrificial coatings, 
adhesion-resisting
Less plaque colonization, 
infections prevention
Kargupta et al. (2014) 
and Rimondini et al. 
(1997)
Toxic to adherent bacteria: 
photoactive coatings, 
metal-impregnated, 
antimicrobial peptides, 
quaternary ammonium salts
Adherent bacteria will 
be killed, infections 
prevention
Campoccia et al. 
(2013), Hasan et al. 
(2013), and Kargupta 
et al. (2014)
Controlled, time-release of 
antibiotics
Adherent bacteria will 
be killed, infections 
prevention
Actis et al., 2013; 
Hasan et al. (2013), 
and Kargupta et al. 
(2014)
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integrin receptor–matrix ligand occurs within minutes after the 
initial surface recognition. Adhesion with proper cell spreading 
then takes several hours during which the cell–implant contact 
area increases 100-fold (Cohen et al., 2004). The adhesion process 
can be greatly influenced by the specific physico-chemical prop-
erties – such as charges, chemistry, wettability, roughness – and 
nano-structuring of the implant surface (Monsees et  al., 2005; 
Ozkucur et al., 2009b; Novaez et al., 2010). Thus, it is extremely 
important to compare those parameters with the outcome of the 
biocompatibility tests.
interaction: implant Surface 
with Microorganism
Implanted devices are prone to biofilm formation. A biofilm is a 
thin but robust layer of microorganisms, such as bacteria, fungi, 
and yeast that adhere to the implant surface similar to the dental 
plaque sticking to the teeth (Actis et  al., 2013; Kargupta et  al., 
2014). These microorganisms can cause serious infections around 
the implant initiating progressive bone loss leading to loosening 
or even loss of the implant (Wood et al., 2004). In case of titanium 
implants, the surface oxide coating achieves an amalgamation 
with the superficial gum that hinders the invasion of oral micro-
organisms. However, the amount of bacterial colonization can be 
influenced by implant surface coating or structuring (Table 1). 
For example, a rougher surface supports bacterial growth and pro-
vides protection from saliva and cleansing by the tongue, whereas 
a smoother surface limits the adhesion of bacteria (Rimondini 
et al., 1997). Because of this interaction, antibacterial activity tests 
should also be considered when testing the biocompatibility of 
a novel coating. Modern antimicrobial coatings are designed to 
prevent biofilm formation by, e.g., preventing bacterial adhesion, 
killing bacteria, or by accelerating osteoblast adhesion (reviewed 
in Hasan et al., 2013; Kargupta et al., 2014).
evALUATiOn OF BiOCOMPATiBiLiTY 
IN VITRO
Structuring, deposition of a thin film, or other modifications 
of the implant surface are crucial parameters in determining 
favorable adhesion and physiological function of cells. Corrosion 
of metal surfaces and release of ions or other leaching products 
can affect cell viability. Both parameters are usually tested using 
in vitro cytotoxicity and adhesion assays with bone cells or fibro-
blasts. Part 5 of ISO 10993 defines standard tests to evaluate the 
cytotoxicity of a medical device using in vitro methods.
Cells
There are two principal classes of cells: established cell lines and 
primary cells. Established cell lines are considered the standard 
for similar research that makes comparison of results and stand-
ardization of procedures possible. Cell lines can be bought com-
mercially from trusted sources, are easy to work with, and can 
be used for many years. However, because these cells can divide 
continuously, they may not reflect the true physiology of the 
original cell. By contrast, primary cells must be isolated directly 
from the body and can be kept in culture for only a limited time. 
factor receptors, focal adhesions also trigger integrin-activated 
signaling cascades leading to osteoblast differentiation and physi-
ological function (Garcia and Reyes, 2005). The establishment of 
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This makes them difficult and expensive to work with; however, 
the results are much closer to the in vivo situation. Often used cell 
types are immortalized neonatal mouse osteoblasts (MC3T3E1), 
human osteosarcoma (SaOS-2 or MG-63), primary rat calvaria 
cells, or L929 mouse fibroblasts (Meyer et al., 2005; Monsees et al., 
2005; Bierbaum et al., 2006; Subramanian et al., 2015).
Cytotoxicity
Cytotoxicity may be tested using an extract or the implant mate-
rial itself. The conditions of extraction should meet the intended 
clinical use. Suitable eluents are cell culture media or physiological 
saline. The tests must include a negative control (culture medium) 
and positive control (e.g., 6% DMSO in culture medium). Cells 
must be incubated for a minimum period of 24  h. For testing 
cytotoxicity in direct cell contact, cells are applied to the surface 
of suitable samples under sterile conditions and then incubated 
for 1–3 days. Alternatively, the implant sample is carefully placed 
on top of the cell layer. Other approved tests are the Agar and the 
Filter Diffusion assay. Both are indirect contact tests that evaluate 
if substances from the implant can be dissolved and move through 
a thin barrier (agar layer or inert filter) toward the cells.
For transparent samples, cell numbers and morphology can 
be checked via simple light microscopy. Living cells should have 
their typical form and are well attached and spread; they usually 
form clusters (Subramanian et al., 2015). Damaged or dying cells 
develop vacuoles, may shrink, become rounder in appearance, 
and eventually detach from the surface. Thus, on a sub-optimal 
surface, cell numbers are lower. For non-transparent samples, 
cells can be visualized using an epifluorescence or scanning 
electron microscope (Ozkucur et  al., 2009a). For quantitative 
measurement of cytotoxicity, suitable parameters are inhibition 
of cell proliferation, numbers of dead and live cells, reduction 
of vital dyes, and release of cytoplasmic enzymes as a result of 
cell membrane damage. The MTT assay measures the activity 
of mitochondrial enzymes, which not only reflects the number 
of viable cells present (used as proliferation assay) but also 
mirrors the degree of mitochondrial activity that indicates cel-
lular stress or dying cells (used as cytotoxicity test). Technically, 
this assay works by reduction of the yellow tetrazolium dye 
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide) to a purple insoluble formazan. This color increase 
can be measured using a photometer. Ozkucur et  al. (2009a) 
showed significantly higher MTT-values, thus more living 
cells attached on metal-coated polyurethane compared to 
the uncoated surfaces. Also, the titanium thin film seems to 
be more favorable for adhesion than the zirconium coating. 
Other related tetrazolium dyes are XTT (2,3-bis-(2-methoxy-
4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide), MTS 
(3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium), and WSTs (water-soluble 
tetrazolium salts). These colorimetric assays provide average 
values off many thousands cells but do not give any information 
about the fate of individual cells. Here, Live/Dead assays using a 
pair of fluorophores are the better choice. The general principle 
is that one of these fluorophores can enter the living cell (intact 
membrane), whereas the other one cannot. The second dye can 
only enter if the cell membrane is compromised indicating a dead 
or dying cell. This second dye usually then binds to DNA in the 
cell nuclei. An example is the calcein-AM – ethidium homodi-
mer, EthD-1 assay that shows living cells in green, whereas dead 
cells emit red fluorescence (Huang et al., 2016).
Cell Adhesion
The sequence leading to cell adhesion and spreading gives us 
some important parameter for additional characterization. There 
are several cellular components that can be visualized, e.g., using 
specific fluorescent dye-tagged antibodies. Often used targets are 
the actin stress fibers that mark the cell morphology; vinculin, a 
protein located in focal adhesions; and DNA to visualize the cell 
nuclei. In this way, different degrees of cell adhesion and spread-
ing can be clearly distinguished (Monsees et al., 2005). Ozkucur 
et  al. (2009a) depicted human umbilical vein endothelial cells 
grown on titanium thin-film-coated polyurethane: cells are well 
spread with regularly organized actin cytoskeleton and many 
focal adhesion contacts. By contrast, cell numbers and spreading 
on the uncoated polyurethane were very poor. Similarly, adhesion 
and spreading of endothelial cells is poor on polyurethane, but is 
dramatically improved on a 30-nm titanium film as shown with 
scanning electron microscopy. The more sophisticated Wound-
Healing assay assesses cell proliferation, actin cytoskeleton 
reorganization, dissolving/renewing of focal adhesion points, 
and migration. Here, cells are grown on the implant surface then 
an open gap is created by removing cells via scratching through 
the confluent cell monolayer. The time for the cells to close this 
“wound” by proliferation, spreading, and moving is monitored 
(Oprea et al., 2003; Bindschadler and McGrath, 2007).
Physiological Cell Function
As the implant surface properties can also influence osteoblast 
differentiation and, thus, ultimately their physiological function, 
more specialized investigations should be considered. Typical 
osteoblast-specific parameters include activity of alkaline phos-
phatase enzyme, secretion of collagen type I, osteopontin or 
osteocalcin, or formation of calcium phosphate deposits (Hempel 
et al., 2004; Meyer et al., 2005). Alkaline phosphatase activity can 
be determined, e.g., via histochemical staining and fluorescence 
microscopy. Monsees et al. (2005) noted regular alkaline phos-
phatase activity in SaOS-2 osteoblasts attached to smooth or 
structured titanium thin films. By contrast, surface composition 
greatly influenced osteopontin expression.
Biodegradation
Material degradation or corrosion within the body can lead to 
loosening and failure of the implant. The impact of body fluids 
on the degradation of metallic implants can be modeled using 
artificial saliva, blood serum, and salt solution (media) normally 
used for tissue culture at 37°C for longer periods of time (days or 
weeks) (ISO 10993 Part 15). Parameters investigated may include 
changes in weight or hardness of the implant material, electro-
chemical behavior, changes of the surface, by means of profilom-
etry, scanning electron or atomic force microscopy, and nature 
and amount of metal ions leaching from the implant assessed by 
X-ray diffraction and atomic emission spectroscopy (Wetzel et al., 
2008; Lesniewicz et al., 2010). It is worthwhile to also compare 
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potential biodegradation with implants that have been in contact 
with cells for the same time and conditions. Depending on the 
surface coating and the underlying bulk material (metal alloy, 
ceramics, or polyurethane), the presence of cells may protect the 
surface, e.g., by secreting extracellular matrix proteins (Ozkucur 
et al., 2009a) or may accelerate especially polymer degradation by 
releasing hydrolytic enzymes (Ozkucur et al., 2009b).
Microbiology
Microorganisms often used in testing the anti-microbiological 
activity of implants include bacteria that can be present in the oral 
cavity, e.g., Staphylococcus aureus and Pseudomonas aeruginosa 
(Gram-negative), and Streptococcus sanguinis and Escherichia 
coli (Gram-positive) (Pye et al., 2009). Two often used tests are 
the Agar Disc Diffusion assay and the Direct Contact method. In 
the agar diffusion assay, the respective single strain of a micro-
organism is spread on solidified agar medium. Then the implant 
sample is gently pressed on the agar and incubated for 24 h at 
37°C. Any antibacterial activity is measured as a zone of inhibi-
tion around the sample disk. A standard implant surface serves 
as “negative control,” whereas an appropriate antibiotic serves as 
positive control (Subramanian et  al., 2015). For direct contact 
method, media containing the respective bacteria are placed 
onto round implant samples and then incubated at 37°C for 24 h. 
Alternatively, implant samples can be incubated on a shaker with 
the respective bacteria suspension. Adhered bacteria populations 
can be visualized after appropriate staining using a stereo-optical 
or epifluorescence microscope or processed for scanning electron 
microscopy (Chung et al., 2006; Patenge et al., 2012).
COnCLUSiOn
The aim of any biomaterial research is to improve the proper-
ties of the implant in certain ways. This may be faster and better 
attachment of osteoblasts or more effective deterring of bacteria. 
In vitro biocompatibility characterization is a means to test such 
potential improvements under precise conditions. Besides the 
mandatory cytotoxicity assay, further tests are recommended 
to investigate the influence of the novel surface modification on 
more complex cellular parameters such as adhesion, morphol-
ogy, differentiation and physiological function. These more 
sophisticated tests will lead to a better understanding of the 
precise interaction between implant surface and surrounding 
cells or microorganisms. The outcome of the biocompatibility 
tests can then be used to steer the surface modification process 
into the desired direction.
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